Clinical Trial Update: Prevalence of Peripheral Arterial Disease in Subject With a Moderate Risk of Cardiovascular (CV) Disease (CVD) in Primary Prevention

View source ↗

Summary

This clinical trial update reports on the prevalence of peripheral arterial disease in subjects with moderate risk of cardiovascular disease in a primary preven…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Arterial Disease

Drugs mentioned

• AstraZeneca

Snippet

Sponsor: AstraZeneca | Conditions: Peripheral Arterial Disease (PAD), Moderate Risk for Cardiovascular Disease (CVD) | Status: COMPLETED